Do you really need some reasons why Blue and I think they're over their heads? I will start a list. Feel free to add as there's so many. At least for anyone without their special beer goggles on that works for management and not the ladies.
- Failed UH deal
- Failed Chinese deal
- Almost 2 years since green light for Japanese trial-hasn't started. Should call it slow track
- over a year delay on closing Sosei deal
- hired a co-ceo as one couldn't cut it
- 3, now 4 orphan drug designations with the first three still doing jack
- Plurisphere
- 2 year delay in development to build manufacturing facilities
- idle manufacturing plant for the most part
- 2 million share bonus...duh didn't see anything wrong with voting for them. Thanks board buddies
- I could write a novel on broken promises/missed milestones but if you need I can fire off another 20 lines in an instant. But I'll spare you unless you ask like you did for this.
- zero partnerships for any of their products aside from ARS. But how long have they said that they would get partners
- others developing ARS treatments got $50 million to over $300 million in development costs. We got trials paid for.
- no CC's
- pocket mans great pocket line
- And the real kicker. A share price that has been around the same as it was 9 years ago. And that would have been much lower if it weren't for this recent run up. Way to go management.
These are things that just popped into my head. I'm sure if I went through previous milestones from years past, there would be a plethora of others.
News 
Market Data 
Discover 
